LEESBURG, Va., June 9, 2014 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq:KTWO) (the “Company” or “K2M”), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced that the underwriters for the Company’s initial public offering exercised their option to purchase 1,000,000 shares of common stock from the selling stockholders at a price of $15.00 per share before underwriting discounts. The closing of the over-allotment option is expected to occur on June 10, 2014. K2M will not receive any proceeds from the sale of these shares.
Help employers find you! Check out all the jobs and post your resume.
